Clinical Trials for Mendus

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Mendus

Clinical Trials (2)

NCT04739527
Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment
PHASE1Active, not recruiting
17 participants
Started: Jun 10, 2021 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT03697707
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia
PHASE2Active, not recruiting
20 participants
Started: Oct 15, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors10 locations